A silver lining for Endocyte

May 2, 2014
Back to TopCommentsE-mailPrintBookmark and Share

The news this morning couldn’t have been worse for Endocyte Inc.

But if it had to come, the timing couldn’t have been better.

The West Lafayette-based drug development firm halted a large clinical trial of its leading cancer drug, vintafolide, for women with ovarian cancer. That sent its stock plunging more than 60 percent.

But the bad news on vintafolide didn’t come until AFTER the drug was given the green light for a market launch by the key regulatory panel in Europe on March 21.

And not until AFTER vintafolide showed promise as a lung cancer drug, also in late-March.

And not until AFTER Endocyte used the investor euphoria that followed those two positive announcements to raise an additional $101.8 million in an April stock offering.

So while CEO Ron Ellis, CFO Mike Sherman and the rest of the team at Endocyte must have felt sick to their stomachs when they read an independent statistical analysis that said vintafolide wasn’t working in ovarian cancer patients, they can at least feel good that the latest stock leaves them a $233 million pile of cash they can use to develop other drugs.

Since the company had a burn rate last year of $83 million (part of which was funded by Merck & Co. Inc., which has purchased the rights to vintafolide), that money should last a while.

Of course, they need it to, because bringing drugs to market is not a quick business. Endocyte was founded by Purdue University chemist Phillip Low in 1995—and it still has no drugs on the market.

And as Endocyte’s see-saw fortunes in just the past six weeks prove, drug development is a brutally risky business.

"Given the set-up, we see this as an overwhelmingly worst-case scenario," wrote Baird Equity Research analyst Christopher Raymond, in a note to investors Friday morning. He added, "We see a long road back to credibility."

Endocyte and Merck are still reviewing the data on vintafolide as an ovarian cancer treatment, so there’s an outside chance the drug might be resurrected in that therapeutic area. But it’s doubtful. The recommendation to halt the Phase 3 clinical trial came from the Data Safety Monitoring Board based on its analysis of progression-free survival in patients. If vintafolide isn’t helping cancer patients live cancer-free longer, then there’s little hope for it.

But vintafolide could still turn out to be effective as a lung cancer drug. And Merck would fund the development of vintafolide on that, too.

The truly worst-case scenario for Endocyte would be for Merck to pull out entirely. That would leave Endocyte with only drugs that are in Phase 1 clinical trials, and probably years to go before reaching the market.

But whatever happens, Endocyte will now spend its cash hoard on its other drugs in development. Those include EC1169, which could treat prostate cancer patients, and EC1456, which some have billed as a better version of vintafolide.

“We are in a strong financial position to continue to advance our promising clinical programs,” Ellis said in a press release this morning.

ADVERTISEMENT

Post a comment to this blog

COMMENTS POLICY
We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
 
You are legally responsible for what you post and your anonymity is not guaranteed.
 
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
 
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
 
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.
 

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by
ADVERTISEMENT
  1. Here are a few candidates for this new group, "ripped from the headlines." First up, that bizzaro State Senator Brent Waltz; secondly, the unethical Todd Huston, and his contractual arrangements scheme; Finally, but not least of all, the dishonorable Eric Turner. What sayeth you Greg Zoeller?

  2. Good day. I can't hide this great testimony that take place in my life I will love everyone to know it and be partaker that is why I always place it on answer, I am Mrs,Natalie Cuttaia by name, I live in Texas, United State Of America, I want to thank (Mr.Bruce Brandon) for his kindness upon my family life. I never knew that there is still nice lender like this on internet and earth here. Just some Months Back, I was in search for a loan of $100,000,00 as I was running out of money for feeding and rent. I was scammed $6,800 Dollars and I decided not to involve my self in such business again but a Friend of my introduced me to a loan firm due to my appearance and doings. And I told him that I am not interested of any loan deal anymore but he told me that there is still a nice lender who he will recommend me to, and I made a trial and I am most grateful lucky am I today, I was given a loan amount of $100,000.00usd, by this great Company (Bruce Brandon Loan Company) managed by (Mr.Bruce Brandon) If you are in need of a genuine or legit loan or financial assistance and you can be reliable and trusted of capable of paying back at the due time of the funds I will advice you to, contact him via: ( bruce.brandon071@gmail.com ) And you will be free from scams in the internet. All thanks to Mr.Bruce Brandon You are the one who remove me and my family out of poverty. The reason why i am doing this is that, i promise Mr.Bruce Brandon that if i truly got my loan, i will advertize his company and bring customers to his company. Contact him via ( bruce.brandon071@gmail.com )for the Loan you have been looking for..

  3. Hello, We are firm Organization formed to help people in needs of helps,such as financial help. So if you are going through financial difficulty or you are in any financial mess,and you need funds to start up your own business,or you need loan to settle your debt or pay off your bills,start a nice business, or you are finding it hard to obtain capital loan from local banks,contact us today via email mrsroseberrywilkinsfunds.usa@gmail.com So do not let these opportunity pass you by because Jesus is the same yesterday, today and forever more. Please these is for serious minded and God fearing People. Your Name: Loan Amount: Loan Duration: Valid Cell Phone Number: Thanks for your understanding to your contact as we Await Regards Management Email:mrsroseberrywilkinsfunds.usa@gmail.com

  4. The question is, where could they build a new stadium? It seems in the past year, all the prime spots have been spoken for with potential projects. Maybe in the industrial wasteland area a block past Lucas Oil? I think it needs to be close to the core, if a new stadium is built.

  5. Aldi is generally a great shopping experience. Still, I'm sure YOU wouldn't want to shop there, which I consider a positive.

ADVERTISEMENT